Sheldon Perry
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Neurology top 5%
- Barrier Structure and Function Studies
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
Papers in
-
- Influenza Virus Research Studies 5
- Pneumonia and Respiratory Infections 1
-
- Advanced Glycation End Products research 2
- Co-authors
- Rashid Deane (2 shared papers)Nathan T. Ross (2 shared papers)Benjamin L. Miller (2 shared papers)Troy J. Zarcone (1 shared paper)Meenakshisundaram Thiyagarajan (1 shared paper)Abhay P. Sagare (1 shared paper)Günter Fritz (1 shared paper)Robert D. Bell (1 shared paper)
- Journals
- PLoS ONE (2 papers)Journal of Clinical Investigation (1 paper)Clinical and Vaccine Immunology (1 paper)Immunology and Cell Biology (1 paper)mBio (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Sheldon Perry
8 papers receiving 636 citations
Sheldon Perry's Hit Papers
Peers
Comparison fields: 5 of 58
- Clinical Biochemistry 222
- Neurology 152
- Physiology 175
- Developmental Neuroscience 8
- Epidemiology 75
Countries citing papers authored by Sheldon Perry
This map shows the geographic impact of Sheldon Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Perry more than expected).
Fields of papers citing papers by Sheldon Perry
This network shows the impact of papers produced by Sheldon Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Perry. The network helps show where Sheldon Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheldon Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease Hit paper breakdown → | 2012 | 549 |
| 2 | 2015 | 30 | |
| 3 | 2018 | 21 | |
| 4 | 2016 | 15 | |
| 5 | 2014 | 14 | |
| 6 | 2021 | 12 | |
| 7 | 2016 | 6 | |
| 8 | 2013 | 3 |
About Sheldon Perry
Sheldon Perry is a scholar working on Epidemiology, Clinical Biochemistry, Physiology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 8 papers that have together received 650 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (5 papers), Alzheimer's disease research and treatments (2 papers), Advanced Glycation End Products research (2 papers) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Clinical Biochemistry (222 citations), Neurology (152 citations), Physiology (175 citations), Developmental Neuroscience (8 citations) and Epidemiology (75 citations). Sheldon Perry has collaborated with scholars based in United States and Germany. Frequent co-authors include Rashid Deane, Nathan T. Ross, Benjamin L. Miller, Troy J. Zarcone, Meenakshisundaram Thiyagarajan, Abhay P. Sagare, Günter Fritz, Robert D. Bell, Rachal Love and Alan E. Friedman. Their work appears in journals such as PLoS ONE, Journal of Clinical Investigation, Clinical and Vaccine Immunology, Immunology and Cell Biology and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.